Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
WiSe 2021
- Wiss. Arbeiten, Abteilung Gastroenterologie (*)
- Klinische Fälle in der Lebertransplantationsambulanz
- Kurs der allgemeinen klinischen Untersuchungen (PV)
- Blockpraktikum Innere Medizin (PV)
- Innere Medizin für Studierende im Praktischen Jahr (*)
- Intensivkurs Sonographie und praktische Einblicke in die Endoskopie
- Gastroenterologisch-internistisch-chirurgisches Kolloquium (*)
-
SoSe 2021
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Extracellular vesicles of patients with acute-on-chronic liver failure induce mitochondrial dysfunction in T cellsIn: Frontiers in Immunology, Jg. 16, 2025, 1656692DOI (Open Access)
-
Prognostic factors for transplant-free survival in patients with secondary sclerosing cholangitis associated with critical illnessIn: BMJ Open Gastroenterology, Jg. 12, 2025, e001571DOI, Online Volltext (Open Access)
-
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma : A comparative analysis in a European real-world cohortIn: Hepatology Communications, Jg. 8, 2024, Nr. 11, e0562DOI (Open Access)
-
Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation : A Multicenter TrialIn: Cancers, Jg. 16, 2024, Nr. 13, 2442DOI (Open Access)
-
Acute cytomegalovirus infection modulates the intestinal microbiota and targets intestinal epithelial cellsIn: European Journal of Immunology, Jg. 53, 2023, Nr. 2, 2249940DOI, Online Volltext (Open Access)
-
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma : Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/BevacizumabIn: Cancers, Jg. 15, 2023, Nr. 17, 4274DOI (Open Access)
-
Evolution of non-thyroidal illness syndrome in acute decompensation of liver cirrhosis and acute-on-chronic liver failureIn: Frontiers in Endocrinology, Jg. 14, 2023, 1104388DOI (Open Access)
-
Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosisIn: JHEP Reports, Jg. 5, 2023, Nr. 4, 100688DOI (Open Access)
-
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies : A multicenter retrospective studyIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, S. 3065 – 3073DOI (Open Access)
-
Pathological neutrophil migration predicts adverse outcomes in hospitalized patients with liver cirrhosisIn: Liver International, Jg. 43, 2023, Nr. 4, S. 896 – 905DOI (Open Access)
-
Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cellsIn: Liver International, 2023, in pressDOI (Open Access)
-
Treating hepatitis D with bulevirtide : Real-world experience from 114 patientsIn: JHEP Reports, Jg. 5, 2023, Nr. 4, 100686DOI (Open Access)
-
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy : A real-world experienceIn: Therapeutic Advances in Medical Oncology, Jg. 14, 2022, 17588359221080298DOI (Open Access)
-
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma : The DEMAND trial protocolIn: Future Oncology, Jg. 18, 2022, Nr. 12, S. 1423 – 1435
-
Cirrhosis-Based Acute-on-Chronic Liver Failure Is Marked by Inflammation and Impaired Liver Regeneration Despite Stat3 ActivationIn: Gastro Hep Advances, Jg. 1, 2022, Nr. 4, S. 520 – 530DOI (Open Access)
-
Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensationIn: PLoS ONE, Jg. 17, 2022, Nr. 2, e0263989DOI (Open Access)
-
FIB-4 and APRI as Predictive Factors for Short-and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent ShuntsIn: Biomedicines, Jg. 10, 2022, Nr. 5, 1018DOI (Open Access)
-
Impaired mitochondrial complex IV respiration in peripheral blood mononuclear cells discriminates acute-on-chronic liver failure from acute decompensationIn: Journal of Hepatology, Jg. 77, 2022, Nr. 3, S. 874 – 876DOI (Open Access)
-
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver CirrhosisIn: Cancers, Jg. 14, 2022, Nr. 19, 4584DOI (Open Access)
-
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationIn: Scientific Reports, Jg. 12, 2022, Nr. 1, 20718DOI, Online Volltext (Open Access)
-
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR) : A Retrospective Multicenter StudyIn: Liver Cancer, Jg. 11, 2022, Nr. 3, S. 219 – 232DOI (Open Access)
-
Safe for Mother, Baby, and Graft? Pregnancy After Liver Transplant : A Single-Center ExperienceIn: Transplantation Proceedings, Jg. 54, 2022, Nr. 3, S. 744 – 748
-
Sorafenib versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma : A Real-World AnalysisIn: Cancers, Jg. 14, 2022, Nr. 8, 1975DOI (Open Access)
-
Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell ModelsIn: Small, 2022, 2201167DOI (Open Access)
-
Cabozantinib in Advanced Hepatocellular Carcinoma : Efficacy and Safety Data from an International Multicenter Real-Life CohortIn: Liver Cancer, Jg. 10, 2021, Nr. 4, S. 360 – 369DOI (Open Access)
-
Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver FailureIn: Frontiers in Immunology, Jg. 11, 2021, S. 534731DOI, Online Volltext (Open Access)
-
Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantationIn: Scientific Reports, Jg. 11, 2021, Nr. 1, 13834DOI, Online Volltext (Open Access)
-
GALAD score detects early-stage hepatocellular carcinoma in a european cohort of chronic hepatitis b and c patientsIn: Pharmaceuticals, Jg. 14, 2021, Nr. 8, 735DOI (Open Access)
-
GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancerIn: Cancer Research, Jg. 81, 2021, Nr. 11, S. 2970 – 2982DOI (Open Access)
-
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure : A multicenter randomized trial (GRAFT study)In: Journal of Hepatology, Jg. 75, 2021, Nr. 6, S. 1346 – 1354DOI (Open Access)
-
Hepatic sarcoidosis : Clinical characteristics and outcomeIn: JHEP Reports, Jg. 3, 2021, Nr. 6, 100360DOI (Open Access)
-
Humoral response to SARS-CoV-2 vaccination in liver transplant recipients : a single-center experienceIn: Vaccines, Jg. 9, 2021, Nr. 7, 738DOI, Online Volltext (Open Access)
-
Hypopituitarism in wilson’s disease resolved after copper-chelating therapyIn: Endocrinology, Diabetes and Metabolism Case Reports, 2021, Nr. 1, 20-0086DOI (Open Access)
-
Mild versus Severe Liver Injury in SARS-CoV-2 InfectionIn: Digestive Diseases, Jg. 39, 2021, Nr. 1, S. 52 – 57DOI, Online Volltext (Open Access)
-
Response to the Letter : Impact of SARS-CoV-2 Infection on Patients Suffering from Liver InjuryIn: Digestive Diseases, Jg. 39, 2021, Nr. 1, S. 68 – 69DOI (Open Access)
-
Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons : Implications for Hepatic ImmunityIn: Frontiers in Immunology, Jg. 11, 2021, S. 581352DOI, Online Volltext (Open Access)
-
[⁶⁸Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinomaIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 9, S. 1235 – 1241DOI (Open Access)
-
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis : comparison of medical and interventional treatmentIn: Alimentary Pharmacology and Therapeutics, Jg. 52, 2020, Nr. 2, S. 329 – 339DOI (Open Access)
-
Alox12/15 Deficiency Exacerbates, While Lipoxin A₄ Ameliorates Hepatic Inflammation in Murine Alcoholic HepatitisIn: Frontiers in Immunology, Jg. 11, 2020, S. 1447DOI (Open Access)
-
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAsIn: Liver International, Jg. 40, 2020, Nr. 3, S. 539 – 548
-
DSM-TACE of HCC : Evaluation of Tumor Response in Patients Ineligible for Other Systemic or Loco-Regional TherapiesIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 192, 2020, Nr. 9, S. 862 – 869
-
Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis : A Systematic Review and Meta-AnalysisIn: Clinical and Translational Gastroenterology, Jg. 11, 2020, Nr. 8, S. e00223DOI (Open Access)
-
Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitorsIn: The Journal of Biological Chemistry (JBC), Jg. 295, 2020, Nr. 40, S. 13862 – 13874DOI (Open Access)
-
Letter to the Editor: Interleukin-22 in acute-on-chronic liver failure : A matter of ineffective levels, receptor dysregulation or defective signalling?In: Journal of Hepatology, Jg. 73, 2020, Nr. 4, S. 980 – 982DOI (Open Access)
-
Quinolone and multidrug resistance predicts failure of antibiotic prophylaxis of spontaneous bacterial peritonitisIn: Clinical Infectious Diseases (CID), Jg. 70, 2020, Nr. 9, S. 1916 – 1924
-
Serum Sphingosine‐1‐Phosphate Is Decreased in Patients With Acute‐on‐Chronic Liver Failure and Predicts Early MortalityIn: Hepatology Communications, Jg. 4, 2020, Nr. 10, S. 1477 – 1486DOI (Open Access)
-
Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosisIn: PLoS ONE, Jg. 15, 2020, Nr. 7, S. e0236528DOI (Open Access)
-
Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory studyIn: Gut Pathogens, Jg. 12, 2020, Nr. 1, S. 51DOI (Open Access)
-
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C treated with DAAs : Results from the German hepatitis C registry (DHC-R)In: Journal of Hepatology, Jg. 70, 2019, Nr. 1 Suppl., S. e232 – e233
-
Establishment of a new animal model for the acute-on-chronic liver failureIn: Journal of Hepatology, Jg. 70, 2019, Nr. 1 Suppl., S. e183
-
IL-22 and IL-22-Binding Protein Are Associated With Development of and Mortality From Acute-on-Chronic Liver Failure.In: Hepatology Communications, Jg. 3, 2019, Nr. 3, S. 392 – 405DOI (Open Access)
-
Impaired adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failureIn: Journal of Hepatology, Jg. 70, 2019, Nr. 1 Suppl., S. e181 – e182
-
Influenza virus infection as precipitating event of acute-on-chronic liver failureIn: Journal of Hepatology, Jg. 70, 2019, Nr. 4, S. 797 – 799DOI (Open Access)
-
Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosisIn: PLoS ONE, Jg. 14, 2019, Nr. 10DOI (Open Access)
-
Use of prothrombin complex concentrates in patients with decompensated liver cirrhosis is associated with thromboembolic eventsIn: Journal of Hepatology, Jg. 70, 2019, Nr. 4, S. 800 – 801DOI (Open Access)
-
Acute-on-Chronic Liver FailureIn: Visceral Medicine, Jg. 34, 2018, Nr. 4, S. 296 – 300DOI (Open Access)
-
Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortalityIn: Liver International, Jg. 38, 2018, Nr. 4, S. 645 – 653
-
Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogsIn: The Journal of Steroid Biochemistry and Molecular Biology, Jg. 183, 2018, S. 142 – 151
-
Glycogen Synthase Kinase 3β Enhances Hepatitis C Virus Replication by Supporting miR-122In: Frontiers in Microbiology, Jg. 9, 2018, S. 2949DOI (Open Access)
-
Immunodysfunction in Acute-on-Chronic Liver FailureIn: Visceral Medicine, Jg. 34, 2018, Nr. 4, S. 276 – 282DOI, Online Volltext (Open Access)
-
Impact and Effectiveness of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis in Times of Multidrug-Resistant Bacteria : A Prospective Observational StudyIn: Hepatology, Jg. 68, 2018, Nr. Suppl. 1, S. 1335A – 1336A
-
Macrophage-derived extracellular vesicles induce long-lasting immunity against hepatitis C virus which is blunted by polyunsaturated fatty acidsIn: Frontiers in Immunology, Jg. 9, 2018, S. 723DOI (Open Access)
-
Managing hepatitis C in patients with the complications of cirrhosisIn: Liver International, Jg. 38, 2018, Nr. Suppl 1, S. 14 – 20DOI (Open Access)
-
Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organismsIn: Infection and Drug Resistance, Jg. 11, 2018, S. 2047 – 2061DOI (Open Access)
-
Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular eventsIn: Hepatology Communications, Jg. 2, 2018, Nr. 7, S. 798 – 806DOI (Open Access)
-
The portal vein as a distinct immunological compartment : A comprehensive immune phenotyping studyIn: Human Immunology, Jg. 79, 2018, Nr. 10, S. 716 – 723
-
Use of Antiplatelet Agents Is Inversely Associated With Liver Fibrosis in Patients With Cardiovascular Disease.In: Hepatology Communications, Jg. 2, 2018, Nr. 12, S. 1601 – 1609DOI (Open Access)
-
Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis : A prospective cohort studyIn: PLoS ONE, Jg. 13, 2018, Nr. 11, S. e0207162DOI (Open Access)
-
Systemic inflammation in hepatorenal syndrome – A target for novel treatment strategies?In: Liver International. Oxford: Wiley, Jg. 39, 2019, Nr. 7, S. 1199 – 1201DOI (Open Access)
-
Single nucleotide polymorphisms of the vitamin D receptor and their impact on vitamin D-and Interleukin-6 levels in liver cirrhosis and acute-on-chronic-liver failure
European-Association-for-the-Study-of-the-Liver Congress; MAY 07-10, 2025; Amsterdam, Netherlands,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 82, 2025, Nr. Suppl. 1, FRI-036 -
FIB-4 and apri-scores predicr long-term outcome in patients with a transjugular intrahepatic portosystemic shuntsIn: Hepatology. Hoboken: Wiley & Sons, Jg. 72, 2020, Nr. Suppl. 1, S. 1106 – 1107DOI (Open Access)
-
Impact and Effectiveness of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis in Times of Multidrug-Resistant Bacteria : A Prospective Observational StudyIn: Hepatology. Hoboken: Wiley & Sons, Jg. 68, 2018, Nr. S1, S. 1335A – 1336A
-
Association of impaired neutrophil migration with adverse outcomes in patients with liver cirrhosis
International Liver Congress 2022 ; 22-26 June 2022, London, UK,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 77, 2022, Nr. Supplement 1: Abstracts of The International Liver CongressTM 2022, S. S340DOI (Open Access) -
LiMAx faciliates patient selection prior radioembolization for patients with hepatocellular carcinoma in liver cirrhosis
The International Liver Congress 2022 ; 22-26 June 2022, London, UK,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 77, 2022, Nr. Supplement 1: Abstracts of The International Liver CongressTM 2022, S. S378 – S379DOI (Open Access) -
Low FT3 levels are associated with acute decompensation and acute-on-chronic liver failure
International Liver Congress 2022 ; 22-26 June 2022, London, UK,In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 77, 2022, Nr. Supplement 1: Abstracts of The International Liver CongressTM 2022, S. S341DOI (Open Access)